Literature DB >> 2089244

[Mortality study of workers employed in the construction of railway cars in Collefero].

F Blasetti1, C Bruno, P Comba, F Fantini, M Grignoli.   

Abstract

The mortality of 276 workers employed in a facility for the manufacturing and maintenance of railroad equipment has been studied in the town of Colleferro (province of Rome). The cohort was based on the 1968 payrolls, and follow-up was conducted up to 1988. Exposure to asbestos took place both during insulation (performed by specialized companies in the same workplaces where study subjects were operating) and during repair work. Mortality for all causes was lower than expected (45 observed, SMR: 71), while mortality from all neoplasms was consistent with expected figures (21 observed, SMR: 107). An increase for respiratory neoplasms was observed (10 observed, SMR: 138); the increase was statistically significant allowing for 20-30 years of latency (7 observed, SMR: 337).

Entities:  

Mesh:

Year:  1990        PMID: 2089244

Source DB:  PubMed          Journal:  Med Lav        ISSN: 0025-7818            Impact factor:   1.275


  4 in total

1.  Cancer mortality among chemical workers in an Italian plant.

Authors:  E Rapiti; F Fantini; V Dell'Orco; V Fano; F Blasetti; C Bracci; F Forastiere; P Comba
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Accuracy of death certification of pleural mesothelioma in Italy.

Authors:  C Bruno; P Comba; P Maiozzi; T Vetrugno
Journal:  Eur J Epidemiol       Date:  1996-08       Impact factor: 8.082

Review 3.  Occupational cancer in Italy.

Authors:  E Merler; P Vineis; D Alhaique; L Miligi
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

4.  Asbestos Ban in Italy: A Major Milestone, Not the Final Cut.

Authors:  Daniela Marsili; Alessia Angelini; Caterina Bruno; Marisa Corfiati; Alessandro Marinaccio; Stefano Silvestri; Amerigo Zona; Pietro Comba
Journal:  Int J Environ Res Public Health       Date:  2017-11-13       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.